Immune cells within tertiary lymphoid structures are associated with progression-free survival in patients with locoregional recurrent breast cancer.

Jinyuan GuJiaming WangYue SunXinrui MaoChao QianXinyu TangJi WangHui XieLijun LingYi ZhaoXiaoan LiuKai ZhangHong PanShui Wang Cong Wang Wenbin Zhou

Published in: Cancer medicine (2023)

Our study proposes potential predictors for the clinical prognosis of patients with locoregional recurrent breast cancer, emphasizing the prognostic value of immune cells within TLSs, especially CD68+ cells.

Keyphrases

free survival
induced apoptosis
cell cycle arrest
oxidative stress
human health
signaling pathway
mass spectrometry
risk assessment
cell proliferation